Author:
Rao Ronisha Shankar,Panbhukarasu Suvetha,Waleed Muhammad,Raichel Cassandra Rifflin Charles,Rahman Kidher,Sivakumar Kameshwaran,Athmanathan Baskaran
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology,Genetics,Biochemistry
Reference81 articles.
1. Lewis EF, Moye LA, Rouleau JL, Sacks FM, Arnold JMO, Warnica JW, et al. Predictors of late development of heart failure in stable survivors of myocardial infarction: the CARE study. J Am Coll Cardiol. 2003;42(8):1446–53.
2. Melendo-Viu M, Abu-Assi E, Manzano-Fernández S, Flores-Blanco PJ, Cambronero-Sánchez F, Pérez DD, et al. Incidence, prognosis and predictors of heart failure after acute myocardial infarction. REC: CardioClinics. 2020;55(1):8–14.
3. Frangogiannis NG. The immune system and cardiac repair. Pharmacol Res. 2008;58(2):88–111.
4. Nahrendorf M, Swirski FK, Aikawa E, Stangenberg L, Wurdinger T, Figueiredo J-L, et al. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med. 2007;204(12):3037–47.
5. O’gara PT, Kushner FG, Ascheim DD, Casey DE Jr, Chung MK, De Lemos JA, et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;127(4):529–55.